| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 19 | 2024 | 285 | 6.460 |
Why?
|
| Photochemotherapy | 7 | 2022 | 49 | 3.560 |
Why?
|
| Heteroptera | 5 | 2024 | 17 | 3.190 |
Why?
|
| Neoplasms | 16 | 2024 | 3027 | 2.870 |
Why?
|
| Photosensitizing Agents | 5 | 2021 | 44 | 2.590 |
Why?
|
| Nanostructures | 8 | 2024 | 66 | 2.370 |
Why?
|
| Mammary Glands, Animal | 10 | 2025 | 477 | 2.220 |
Why?
|
| Mammary Neoplasms, Experimental | 6 | 2025 | 246 | 2.030 |
Why?
|
| Antineoplastic Agents | 11 | 2021 | 1850 | 2.010 |
Why?
|
| Hydrogen Peroxide | 7 | 2023 | 130 | 1.900 |
Why?
|
| Ferrous Compounds | 3 | 2021 | 10 | 1.570 |
Why?
|
| Animals | 64 | 2025 | 36398 | 1.570 |
Why?
|
| Metal-Organic Frameworks | 2 | 2021 | 5 | 1.470 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 3849 | 1.430 |
Why?
|
| Zeolites | 2 | 2021 | 3 | 1.430 |
Why?
|
| Mice | 46 | 2025 | 18911 | 1.380 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 690 | 1.380 |
Why?
|
| Skin Neoplasms | 5 | 2023 | 907 | 1.320 |
Why?
|
| Hydroxyl Radical | 5 | 2023 | 14 | 1.300 |
Why?
|
| Breast Neoplasms | 13 | 2025 | 2764 | 1.300 |
Why?
|
| Metal Nanoparticles | 4 | 2024 | 59 | 1.260 |
Why?
|
| Iron | 3 | 2021 | 303 | 1.250 |
Why?
|
| Cell Line, Tumor | 21 | 2024 | 3751 | 1.250 |
Why?
|
| Phylogeny | 5 | 2024 | 784 | 1.230 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 246 | 1.150 |
Why?
|
| Phylogeography | 2 | 2024 | 20 | 1.110 |
Why?
|
| Magnesium | 2 | 2024 | 127 | 1.090 |
Why?
|
| Climate Change | 2 | 2024 | 63 | 1.040 |
Why?
|
| Gadolinium | 5 | 2020 | 117 | 1.040 |
Why?
|
| Cerium | 3 | 2024 | 3 | 0.990 |
Why?
|
| Cellular Senescence | 3 | 2024 | 201 | 0.970 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4776 | 0.930 |
Why?
|
| Free Radicals | 2 | 2024 | 39 | 0.910 |
Why?
|
| Alginates | 1 | 2024 | 26 | 0.910 |
Why?
|
| Gold | 1 | 2024 | 57 | 0.900 |
Why?
|
| Energy Transfer | 2 | 2024 | 18 | 0.890 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 38 | 0.890 |
Why?
|
| Cancer Pain | 1 | 2024 | 28 | 0.890 |
Why?
|
| Optogenetics | 1 | 2024 | 76 | 0.880 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 46 | 0.880 |
Why?
|
| Endopeptidases | 1 | 2024 | 118 | 0.880 |
Why?
|
| Tyrosine | 1 | 2024 | 158 | 0.870 |
Why?
|
| Zinc | 1 | 2024 | 141 | 0.870 |
Why?
|
| Epithelial Cells | 8 | 2024 | 941 | 0.860 |
Why?
|
| Biodiversity | 1 | 2024 | 89 | 0.860 |
Why?
|
| Carbon | 1 | 2024 | 99 | 0.860 |
Why?
|
| Hydrogels | 1 | 2024 | 110 | 0.850 |
Why?
|
| Genetic Vectors | 4 | 2020 | 970 | 0.850 |
Why?
|
| Dopaminergic Neurons | 1 | 2024 | 51 | 0.840 |
Why?
|
| Cranial Irradiation | 1 | 2024 | 72 | 0.840 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 1410 | 0.840 |
Why?
|
| Hemiptera | 1 | 2023 | 19 | 0.830 |
Why?
|
| NF-kappa B | 2 | 2024 | 482 | 0.820 |
Why?
|
| Glutathione | 4 | 2023 | 201 | 0.820 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 141 | 0.800 |
Why?
|
| Keloid | 1 | 2022 | 11 | 0.800 |
Why?
|
| Cysteine | 2 | 2020 | 142 | 0.800 |
Why?
|
| Apoptosis | 9 | 2024 | 1931 | 0.790 |
Why?
|
| Wound Infection | 1 | 2022 | 54 | 0.780 |
Why?
|
| Stem Cells | 4 | 2021 | 753 | 0.780 |
Why?
|
| Carcinogenesis | 6 | 2021 | 364 | 0.780 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2022 | 6 | 0.770 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2023 | 129 | 0.770 |
Why?
|
| Precancerous Conditions | 3 | 2023 | 288 | 0.770 |
Why?
|
| Genome, Mitochondrial | 1 | 2022 | 34 | 0.750 |
Why?
|
| Oncolytic Viruses | 1 | 2022 | 77 | 0.750 |
Why?
|
| Pseudopodia | 1 | 2021 | 9 | 0.740 |
Why?
|
| Oncolytic Virotherapy | 1 | 2022 | 89 | 0.730 |
Why?
|
| Keratosis, Actinic | 1 | 2021 | 14 | 0.730 |
Why?
|
| Ferric Compounds | 2 | 2021 | 41 | 0.730 |
Why?
|
| Humans | 63 | 2025 | 133932 | 0.730 |
Why?
|
| Autophagy | 2 | 2023 | 423 | 0.720 |
Why?
|
| Melanoma | 4 | 2024 | 975 | 0.720 |
Why?
|
| Platinum | 1 | 2021 | 13 | 0.720 |
Why?
|
| Aminolevulinic Acid | 2 | 2021 | 12 | 0.720 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 644 | 0.710 |
Why?
|
| Cell Proliferation | 12 | 2024 | 2539 | 0.710 |
Why?
|
| Phosphotungstic Acid | 1 | 2020 | 2 | 0.700 |
Why?
|
| DNA, Catalytic | 1 | 2020 | 4 | 0.700 |
Why?
|
| Tumor Hypoxia | 1 | 2020 | 6 | 0.700 |
Why?
|
| Chlorine | 1 | 2020 | 17 | 0.690 |
Why?
|
| Gene Editing | 1 | 2023 | 212 | 0.690 |
Why?
|
| Thermography | 1 | 2020 | 12 | 0.670 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 226 | 0.670 |
Why?
|
| Imidazoles | 1 | 2021 | 217 | 0.650 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 205 | 0.650 |
Why?
|
| Neurons | 3 | 2024 | 2035 | 0.640 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2019 | 6 | 0.640 |
Why?
|
| Oncogenes | 4 | 2024 | 179 | 0.630 |
Why?
|
| China | 8 | 2024 | 295 | 0.630 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 107 | 0.630 |
Why?
|
| Transfection | 2 | 2020 | 1089 | 0.620 |
Why?
|
| Lentivirus | 5 | 2020 | 86 | 0.620 |
Why?
|
| Cisplatin | 2 | 2018 | 287 | 0.620 |
Why?
|
| Silver Compounds | 1 | 2018 | 7 | 0.600 |
Why?
|
| Insecta | 2 | 2022 | 67 | 0.580 |
Why?
|
| Prodrugs | 1 | 2018 | 62 | 0.580 |
Why?
|
| Membrane Proteins | 2 | 2024 | 1607 | 0.580 |
Why?
|
| Phosphates | 1 | 2018 | 119 | 0.580 |
Why?
|
| Oxygen | 2 | 2018 | 577 | 0.570 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2021 | 111 | 0.560 |
Why?
|
| DNA Helicases | 1 | 2019 | 251 | 0.560 |
Why?
|
| Surface Properties | 4 | 2021 | 95 | 0.550 |
Why?
|
| Contrast Media | 4 | 2024 | 512 | 0.550 |
Why?
|
| Particle Size | 4 | 2021 | 148 | 0.550 |
Why?
|
| Rats | 5 | 2025 | 3885 | 0.540 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 931 | 0.540 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 333 | 0.540 |
Why?
|
| Keratin-6 | 4 | 2016 | 13 | 0.530 |
Why?
|
| Receptor, ErbB-2 | 5 | 2016 | 559 | 0.520 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1334 | 0.520 |
Why?
|
| Catalysis | 3 | 2021 | 138 | 0.510 |
Why?
|
| Cell Survival | 6 | 2021 | 891 | 0.510 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2016 | 74 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 2122 | 0.500 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 525 | 0.480 |
Why?
|
| RNA, Ribosomal | 2 | 2012 | 62 | 0.470 |
Why?
|
| Keratoderma, Palmoplantar | 2 | 2025 | 6 | 0.470 |
Why?
|
| Gene Transfer Techniques | 2 | 2023 | 365 | 0.460 |
Why?
|
| Serpins | 2 | 2025 | 34 | 0.460 |
Why?
|
| Silicon Dioxide | 4 | 2020 | 31 | 0.460 |
Why?
|
| X-Rays | 3 | 2021 | 30 | 0.450 |
Why?
|
| Micelles | 2 | 2024 | 21 | 0.450 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 999 | 0.450 |
Why?
|
| Female | 39 | 2025 | 71659 | 0.430 |
Why?
|
| Boron Compounds | 2 | 2024 | 34 | 0.430 |
Why?
|
| Electrons | 3 | 2023 | 27 | 0.420 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2013 | 4 | 0.410 |
Why?
|
| Oxidative Stress | 3 | 2024 | 870 | 0.410 |
Why?
|
| Oxidation-Reduction | 4 | 2023 | 465 | 0.400 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 2527 | 0.400 |
Why?
|
| Porphyrins | 2 | 2024 | 18 | 0.400 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 241 | 0.390 |
Why?
|
| Wnt Proteins | 1 | 2013 | 223 | 0.390 |
Why?
|
| Archaea | 1 | 2012 | 13 | 0.380 |
Why?
|
| Eukaryota | 1 | 2012 | 24 | 0.380 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1623 | 0.380 |
Why?
|
| Action Potentials | 2 | 2024 | 524 | 0.360 |
Why?
|
| Infrared Rays | 2 | 2021 | 28 | 0.360 |
Why?
|
| Ribosomes | 1 | 2012 | 139 | 0.360 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 292 | 0.360 |
Why?
|
| Cell Nucleus | 2 | 2024 | 688 | 0.360 |
Why?
|
| Unemployment | 2 | 2021 | 23 | 0.350 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1789 | 0.350 |
Why?
|
| Bayes Theorem | 3 | 2022 | 314 | 0.350 |
Why?
|
| HeLa Cells | 4 | 2020 | 828 | 0.340 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 107 | 0.330 |
Why?
|
| Retroviridae | 3 | 2023 | 198 | 0.330 |
Why?
|
| Magnetic Fields | 2 | 2021 | 7 | 0.330 |
Why?
|
| Transcription Factors | 1 | 2019 | 2704 | 0.310 |
Why?
|
| Phototherapy | 2 | 2022 | 39 | 0.300 |
Why?
|
| Cell Movement | 3 | 2022 | 917 | 0.300 |
Why?
|
| Methylmercury Compounds | 2 | 2018 | 5 | 0.290 |
Why?
|
| Seafood | 2 | 2018 | 10 | 0.290 |
Why?
|
| Mice, Nude | 5 | 2021 | 777 | 0.270 |
Why?
|
| Nanotechnology | 2 | 2020 | 52 | 0.270 |
Why?
|
| Quality of Life | 3 | 2022 | 2134 | 0.260 |
Why?
|
| Bone Neoplasms | 2 | 2024 | 447 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 1079 | 0.260 |
Why?
|
| Cell Plasticity | 2 | 2017 | 36 | 0.250 |
Why?
|
| Wound Healing | 2 | 2022 | 496 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2019 | 248 | 0.250 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 505 | 0.250 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 132 | 0.240 |
Why?
|
| beta Catenin | 3 | 2023 | 229 | 0.240 |
Why?
|
| Glycolysis | 2 | 2024 | 170 | 0.240 |
Why?
|
| Genes, Reporter | 4 | 2020 | 395 | 0.230 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 252 | 0.230 |
Why?
|
| Gelatinases | 1 | 2024 | 16 | 0.230 |
Why?
|
| Borohydrides | 1 | 2024 | 3 | 0.230 |
Why?
|
| Heterocyclic Compounds | 1 | 2024 | 18 | 0.230 |
Why?
|
| Electrodes | 1 | 2024 | 97 | 0.230 |
Why?
|
| Melanins | 1 | 2024 | 20 | 0.230 |
Why?
|
| Liver | 2 | 2024 | 1875 | 0.230 |
Why?
|
| Animal Distribution | 1 | 2024 | 16 | 0.220 |
Why?
|
| Epidermis | 1 | 2024 | 67 | 0.220 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 112 | 0.220 |
Why?
|
| Analgesia | 1 | 2024 | 43 | 0.220 |
Why?
|
| Benzopyrans | 1 | 2024 | 21 | 0.220 |
Why?
|
| Diffusion | 1 | 2024 | 58 | 0.220 |
Why?
|
| Electricity | 1 | 2023 | 10 | 0.220 |
Why?
|
| Light | 1 | 2024 | 187 | 0.220 |
Why?
|
| Motor Cortex | 1 | 2024 | 90 | 0.220 |
Why?
|
| Signal Transduction | 8 | 2024 | 4900 | 0.220 |
Why?
|
| Cysteine Endopeptidases | 1 | 2024 | 119 | 0.220 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 19 | 0.210 |
Why?
|
| Analgesics | 1 | 2024 | 134 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 508 | 0.210 |
Why?
|
| Boron | 1 | 2022 | 3 | 0.200 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2022 | 15 | 0.200 |
Why?
|
| Peptidoglycan | 1 | 2022 | 22 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2022 | 26 | 0.200 |
Why?
|
| Male | 13 | 2025 | 65882 | 0.200 |
Why?
|
| India | 1 | 2023 | 238 | 0.200 |
Why?
|
| Biological Evolution | 1 | 2024 | 256 | 0.200 |
Why?
|
| CD40 Ligand | 1 | 2022 | 65 | 0.200 |
Why?
|
| Neoptera | 1 | 2022 | 1 | 0.200 |
Why?
|
| Thiazoles | 1 | 2023 | 102 | 0.200 |
Why?
|
| Nanomedicine | 1 | 2022 | 25 | 0.190 |
Why?
|
| Microbubbles | 1 | 2022 | 12 | 0.190 |
Why?
|
| Fluorides | 2 | 2019 | 21 | 0.190 |
Why?
|
| Acoustics | 1 | 2022 | 23 | 0.190 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 114 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 258 | 0.190 |
Why?
|
| Proteogenomics | 1 | 2023 | 102 | 0.190 |
Why?
|
| Nucleic Acid Conformation | 2 | 2013 | 198 | 0.190 |
Why?
|
| Electric Impedance | 1 | 2022 | 68 | 0.190 |
Why?
|
| Dermabrasion | 1 | 2021 | 4 | 0.190 |
Why?
|
| Mitochondria | 2 | 2024 | 747 | 0.190 |
Why?
|
| Drug Carriers | 2 | 2023 | 119 | 0.190 |
Why?
|
| Temperature | 2 | 2020 | 330 | 0.180 |
Why?
|
| Nitrosative Stress | 1 | 2021 | 3 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 352 | 0.180 |
Why?
|
| Metformin | 1 | 2023 | 162 | 0.180 |
Why?
|
| Hydrogenation | 1 | 2021 | 2 | 0.180 |
Why?
|
| Dietary Exposure | 2 | 2018 | 3 | 0.180 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.180 |
Why?
|
| Oryza | 1 | 2021 | 29 | 0.180 |
Why?
|
| NAD | 1 | 2021 | 47 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 1310 | 0.180 |
Why?
|
| Metals, Heavy | 1 | 2021 | 24 | 0.180 |
Why?
|
| Lysosomes | 1 | 2023 | 262 | 0.180 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 15 | 0.180 |
Why?
|
| Fluorescence | 2 | 2018 | 103 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 320 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 351 | 0.170 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 26 | 0.170 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2020 | 12 | 0.170 |
Why?
|
| Silver | 1 | 2020 | 29 | 0.170 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 11 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 2 | 2018 | 91 | 0.170 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 35 | 0.170 |
Why?
|
| Neuroprotection | 1 | 2020 | 31 | 0.170 |
Why?
|
| Metallocenes | 1 | 2020 | 2 | 0.170 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 828 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2023 | 610 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 667 | 0.170 |
Why?
|
| Hyperthermia, Induced | 2 | 2018 | 59 | 0.160 |
Why?
|
| Fibroblasts | 2 | 2022 | 922 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 456 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2520 | 0.160 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 407 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2020 | 813 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 66 | 0.160 |
Why?
|
| Spine | 1 | 2020 | 147 | 0.160 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 73 | 0.160 |
Why?
|
| Bismuth | 1 | 2020 | 83 | 0.160 |
Why?
|
| Calcium Carbonate | 1 | 2019 | 11 | 0.160 |
Why?
|
| Plasmids | 1 | 2020 | 527 | 0.160 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 484 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2020 | 129 | 0.160 |
Why?
|
| Theranostic Nanomedicine | 2 | 2017 | 7 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 275 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2013 | 789 | 0.160 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2020 | 152 | 0.160 |
Why?
|
| Polymers | 1 | 2020 | 121 | 0.150 |
Why?
|
| Sepsis | 1 | 2024 | 516 | 0.150 |
Why?
|
| Skin Diseases | 1 | 2020 | 135 | 0.150 |
Why?
|
| A549 Cells | 1 | 2018 | 49 | 0.150 |
Why?
|
| Computational Biology | 3 | 2014 | 887 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2023 | 1002 | 0.150 |
Why?
|
| Juglandaceae | 1 | 2018 | 1 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 291 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 197 | 0.150 |
Why?
|
| Lithium Compounds | 1 | 2018 | 16 | 0.150 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 73 | 0.150 |
Why?
|
| Bacteria | 1 | 2022 | 535 | 0.150 |
Why?
|
| Copper | 1 | 2018 | 75 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 305 | 0.150 |
Why?
|
| Diptera | 1 | 2018 | 27 | 0.150 |
Why?
|
| DNA | 1 | 2024 | 1675 | 0.150 |
Why?
|
| Histones | 1 | 2022 | 568 | 0.150 |
Why?
|
| Food Contamination | 1 | 2018 | 29 | 0.150 |
Why?
|
| Inflammation | 2 | 2024 | 1599 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2020 | 474 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 1833 | 0.140 |
Why?
|
| Base Sequence | 2 | 2013 | 3171 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2024 | 2026 | 0.140 |
Why?
|
| Electrochemical Techniques | 1 | 2017 | 6 | 0.140 |
Why?
|
| Astacoidea | 1 | 2017 | 2 | 0.140 |
Why?
|
| Naphthoquinones | 1 | 2017 | 9 | 0.140 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 39 | 0.140 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 38 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4821 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 2161 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2022 | 749 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 2196 | 0.130 |
Why?
|
| Middle Aged | 4 | 2024 | 29394 | 0.130 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3970 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 56 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2024 | 1621 | 0.130 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 68 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 309 | 0.130 |
Why?
|
| Muscles | 1 | 2017 | 307 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 110 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 616 | 0.130 |
Why?
|
| Polylysine | 1 | 2016 | 11 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 470 | 0.130 |
Why?
|
| Iron Compounds | 1 | 2016 | 2 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 749 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2940 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 388 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 648 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 399 | 0.110 |
Why?
|
| Claudins | 1 | 2014 | 31 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 83 | 0.110 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 612 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2016 | 1409 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 971 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 221 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 159 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3167 | 0.110 |
Why?
|
| Tungsten Compounds | 1 | 2013 | 3 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1911 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 874 | 0.110 |
Why?
|
| Ischemia | 1 | 2017 | 383 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 108 | 0.110 |
Why?
|
| Anxiety | 1 | 2020 | 993 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 37 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17481 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2014 | 247 | 0.100 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 56 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2024 | 1702 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 12 | 0.100 |
Why?
|
| Adult | 5 | 2025 | 31946 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 230 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2016 | 375 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 65 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 71 | 0.100 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 19 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Contig Mapping | 1 | 2012 | 56 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 490 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2013 | 298 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2012 | 122 | 0.090 |
Why?
|
| Base Pairing | 1 | 2012 | 42 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 100 | 0.090 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 14 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1720 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 463 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1350 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2013 | 633 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 303 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 267 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 792 | 0.080 |
Why?
|
| I-kappa B Kinase | 2 | 2024 | 61 | 0.080 |
Why?
|
| Chromatin | 2 | 2023 | 609 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 435 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 1371 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 399 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2024 | 3980 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 711 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 88 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 821 | 0.070 |
Why?
|
| Brain | 2 | 2017 | 3220 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2021 | 13011 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1066 | 0.070 |
Why?
|
| Software | 1 | 2012 | 737 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 510 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 1315 | 0.070 |
Why?
|
| Keratins | 1 | 2006 | 52 | 0.060 |
Why?
|
| DNA Damage | 1 | 2010 | 546 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2012 | 1003 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 697 | 0.060 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2025 | 11 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 613 | 0.060 |
Why?
|
| Founder Effect | 1 | 2025 | 34 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 7204 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 87 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2018 | 302 | 0.060 |
Why?
|
| Caspase 8 | 1 | 2024 | 24 | 0.060 |
Why?
|
| Introns | 1 | 2025 | 313 | 0.060 |
Why?
|
| Caspase 1 | 1 | 2024 | 45 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 1735 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2024 | 139 | 0.050 |
Why?
|
| Polyphenols | 1 | 2023 | 25 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2025 | 250 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1006 | 0.050 |
Why?
|
| Haplotypes | 1 | 2025 | 562 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 104 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 39 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 401 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1196 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 82 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 203 | 0.050 |
Why?
|
| Exons | 1 | 2025 | 832 | 0.050 |
Why?
|
| Aged | 2 | 2021 | 21730 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2013 | 183 | 0.050 |
Why?
|
| Skin | 1 | 2025 | 551 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3739 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6588 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 183 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 89 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 168 | 0.040 |
Why?
|
| Mutation | 3 | 2025 | 6297 | 0.040 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2020 | 6 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 17 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2020 | 20 | 0.040 |
Why?
|
| Chromogranins | 1 | 2020 | 29 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 86 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 65 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 382 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 240 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 215 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 962 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 188 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 258 | 0.040 |
Why?
|
| Prognosis | 2 | 2023 | 5074 | 0.040 |
Why?
|
| Carya | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 318 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 127 | 0.040 |
Why?
|
| Risperidone | 1 | 2018 | 60 | 0.040 |
Why?
|
| Luminescent Agents | 1 | 2017 | 6 | 0.040 |
Why?
|
| Osteocytes | 1 | 2017 | 14 | 0.030 |
Why?
|
| Selenium | 1 | 2017 | 20 | 0.030 |
Why?
|
| Life Style | 1 | 2020 | 454 | 0.030 |
Why?
|
| Fishes | 1 | 2017 | 41 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 486 | 0.030 |
Why?
|
| Cities | 1 | 2017 | 51 | 0.030 |
Why?
|
| Zebrafish | 1 | 2020 | 417 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 125 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 153 | 0.030 |
Why?
|
| Mental Health | 1 | 2020 | 372 | 0.030 |
Why?
|
| Intestines | 1 | 2021 | 614 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 920 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2017 | 74 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1977 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 773 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 218 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1418 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 413 | 0.030 |
Why?
|
| Glass | 1 | 2016 | 12 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 11087 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 235 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2015 | 47 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1909 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 232 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 613 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 102 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1705 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2162 | 0.030 |
Why?
|
| Virus Latency | 1 | 2015 | 64 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 63 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 388 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 17 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 151 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 25 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 104 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 70 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 42 | 0.030 |
Why?
|
| Materials Testing | 1 | 2013 | 80 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2239 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 120 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 199 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 141 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2654 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 369 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 2 | 0.030 |
Why?
|
| Colloids | 1 | 2013 | 17 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1143 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 296 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 47 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 76 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2012 | 11 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 25 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 371 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 29 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 395 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 58 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 125 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6664 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 327 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2013 | 236 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 791 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 167 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1735 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 184 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 307 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3695 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 260 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 644 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 708 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 544 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3990 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 905 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1533 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 1410 | 0.020 |
Why?
|
| Keratin-9 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Alpharetrovirus | 1 | 2008 | 5 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2837 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 96 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 99 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 924 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3054 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 195 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 276 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 1046 | 0.010 |
Why?
|